Novo Nordisk
NVO
1,395 hedge funds and large institutions have $16.7B invested in Novo Nordisk in 2025 Q3 according to their latest regulatory filings, with 159 funds opening new positions, 502 increasing their positions, 550 reducing their positions, and 224 closing their positions.
0.23% less ownership
Funds ownership: 9.1% → 8.87% (-0.23%)
9% less repeat investments, than reductions
Existing positions increased: 502 | Existing positions reduced: 550
6% less funds holding
Funds holding: 1,481 → 1,395 (-86)
22% less capital invested
Capital invested by funds: $21.3B → $16.7B (-$4.59B)
29% less first-time investments, than exits
New positions opened: 159 | Existing positions closed: 224
32% less call options, than puts
Call options by funds: $2.04B | Put options by funds: $2.99B
32% less funds holding in top 10
Funds holding in top 10: 25 → 17 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$800M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$357M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$326M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$210M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$160M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$1.03B |
| 2 |
ClearBridge Investments
New York
|
-$429M |
| 3 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$362M |
| 4 |
Fayez Sarofim & Co
Houston,
Texas
|
-$184M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$145M |
NVO Hedge Fund Activity: Q3 2025 in Review
1,395 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2025, worth a combined $16.7B — down 22% from $21.3B a quarter earlier.
Sellers outnumbered buyers: 224 funds closed out of NVO and 159 opened new positions — a net loss of 65 holders — while 550 trimmed existing stakes and 502 added.
The largest buyer was Franklin Resources, adding an estimated $800M. The largest seller was Jennison Associates, cutting an estimated $1.03B.
- 1,395 institutional investors held Novo Nordisk (NVO) as of Q3 2025, down from 1,481 in Q2 2025.
- Funds reported $16.7B of Novo Nordisk stock for Q3 2025, down 22% quarter-over-quarter.
- 159 funds opened new Novo Nordisk positions in Q3 2025 and 224 closed out, a net change of -65 holders.
- The largest Novo Nordisk buyer in Q3 2025 was Franklin Resources, an estimated $800M added.
- The largest Novo Nordisk seller in Q3 2025 was Jennison Associates, an estimated $1.03B sold.
Based on aggregated 13F filings for Q3 2025.